Mirna Therapeutics
Latest round
- Series D
Last raised
- May 2015
Total raised
- $78M
Investors
- 12
About Mirna Therapeutics
Founded in 2007 and based in Texas, US, Mirna Therapeutics, Inc. is a biopharmaceutical company that develops microRNA-based therapeutics for the treatment of liver cancer and hematological malignancies.8 million, and in May 2017, it merged with Synlogic, Inc.
Who invested in Mirna Therapeutics
12 investors across 3 rounds
See all investors in Mirna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mirna Therapeutics
Who invested in Mirna Therapeutics?
Mirna Therapeutics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mirna Therapeutics raised?
Mirna Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mirna Therapeutics last raise money?
Mirna Therapeutics's most recent round on record is a Series D, in May 2015.
What does Mirna Therapeutics do?
Founded in 2007 and based in Texas, US, Mirna Therapeutics, Inc.
Where is Mirna Therapeutics headquartered?
Mirna Therapeutics is headquartered in Austin, US.
Which VCs invest in companies like Mirna Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Mirna Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Mirna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.